Podcast: Making Science Open to All

There are very few sciences Dr. Strasser hasn't studied, from mathematics to engineering and biology. Now she is the CSO of Pepper Bio, a drug discovery company that uses AI and other clever algorithms to treat patients more effectively. In short, Dr. Strasser is using her gifts to help others and it was inspiring and right-sizing to speak with such a humble trailblazer. Listen here to learn how Pepper is…

Comments Off on Podcast: Making Science Open to All

Startup Pepper Bio Touts ‘Transomics’ as Key Strategy in its Drug Discovery Efforts

Reposted from Neil Versel, Editor at GenomeWeb CHICAGO – While multiomics seems to be a top biotech buzzword these days, drug discovery and bioinformatics startup Pepper Bio is trying to make a name for itself in the field of transomics. To that end, the Boston-based startup is leveraging support from Merck and other entities as part of an accelerator program to try and hone its strategy for applications such as…

Comments Off on Startup Pepper Bio Touts ‘Transomics’ as Key Strategy in its Drug Discovery Efforts

Ex-Phio VP, Simon Fricker, Joins Pepper Bio As Chief Development Officer

By Jon Hu, CEO and Cofounder of Pepper Bio  Pepper Bio, the world’s first transomics drug discovery company, announced the addition of Simon Fricker, Ph.D., as chief development officer. Previously, Dr. Fricker served three years as vice president of research and development at Phio Pharmaceuticals, a publicly-traded clinical-stage biotechnology company, and eight years as a distinguished scientific fellow at Genzyme/Sanofi. In his new role at Pepper, Dr. Fricker will support the…

Comments Off on Ex-Phio VP, Simon Fricker, Joins Pepper Bio As Chief Development Officer

Podcast: Transforming Drug Discovery Through the Emerging Discipline of Transomics

Samantha Dale Strasser has always wanted to make a positive impact on humanity, and this desire was intensified while in grad school when her father was diagnosed with frontal temporal dementia — an illness with no effective treatments. Never afraid to ask the hard questions, this personal experience propelled her academic and biotech career toward driving science to address unmet medical needs. Using her skills in biomedical engineering, computer science,…

Comments Off on Podcast: Transforming Drug Discovery Through the Emerging Discipline of Transomics

Podcast: Transomic Data Analysis Driving New Understanding of Diseases

Dr. Samantha Dale Strasser, Chief Scientific Officer and Co-Founder at Pepper Bio, uses a transomic perspective with a global functional causal lens on genomic data to drive insights throughout the drug discovery process and identify the best treatments for patients. The goal is to go beyond the traditional understanding of diseases to unlock opportunities and solutions not considered in the past. Samantha explains, "So, I mentioned the genome is fantastic because…

Comments Off on Podcast: Transomic Data Analysis Driving New Understanding of Diseases

Pharma’s Blind Spot: Successfully Using AI To Drive Drug Development

Jon Hu Forbes Councils Member Artificial intelligence (AI) has penetrated nearly every industry, but the pharmaceutical industry could arguably benefit from AI the most. According to the results of a study performed by Insider Intelligence, AI has the potential to curb drug discovery costs for pharma companies by nearly 70%. It can do this by making accurate, more nuanced predictions about a disease or drug. However, if the data feeding into…

Comments Off on Pharma’s Blind Spot: Successfully Using AI To Drive Drug Development